Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

American Journal of Kidney Diseases

Volumn 52, Issue 3, 2008, Pages 519-530

  Tentori, Francesca ^a   Blayney, Margaret J ^a   Albert, Justin M ^a   Gillespie, Brenda W ^a   Kerr, Peter G ^b   Bommer, Jürgen ^c   Young, Eric W ^a   Akizawa, Tadao ^d   Akiba, Takashi ^e   Pisoni, Ronald L ^a   Robinson, Bruce M ^a   Port, Friedrich K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d SHOWA UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

cardiovascular disease; Dialysis Outcomes and Practice Patterns Study (DOPPS); guidelines; Hemodialysis; mineral metabolism

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; AUSTRALASIA; CALCIUM; COHORT STUDIES; EUROPE; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NORTH AMERICA; PARATHYROID HORMONE; PHOSPHORUS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 49749113618     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.03.020     Document Type: Article

References (37)

1. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
2. Qunibi W.Y., Nolan C.A., and Ayus J.C. Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon. Kidney Int Suppl 82 (2002) S73-S80
3. Kestenbaum B., Sampson J.N., Rudser K.D., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16 (2005) 520-528
4. London G.M., Guerin A.P., Verbeke F.H., et al. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18 (2007) 613-620
5. Krasniak A., Drozdz M., Pasowicz M., et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 22 (2007) 515-521
6. Block G.A., Klassen P.S., Lazarus J.M., et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 (2004) 2208-2218
7. Melamed M.L., Eustace J.A., Plantinga L., et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int 70 (2006) 351-357
8. Moe S., Drueke T., Cunningham J., et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69 (2006) 1945-1953
9. Stevens L.A., Djurdjev O., Cardew S., Cameron E.C., and Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 15 (2004) 770-779
10. Noordzij M., Korevaar J.C., Boeschoten E.W., et al. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association with mortality in dialysis patients. Am J Kidney Dis 46 (2005) 925-932
11. Tentori F., Hunt W.C., Rohrscheib M., et al. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?. J Am Soc Nephrol 18 (2007) 2377-2384
12. Young E.W., Akiba T., Albert J.M., et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Am J Kidney Dis 44 suppl 2 (2004) S34-S38
13. Young E.W., Albert J.M., Satayathum S., et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67 (2005) 1179-1187
14. Kalantar-Zadeh K., Kuwae N., Regidor D.L., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70 (2006) 771-780
15. Tanaka M., Yamazaki S., Hayashino Y., et al. Hypercalcaemia is associated with poor mental health in haemodialysis patients: Results from Japan DOPPS. Nephrol Dial Transplant 22 (2007) 1658-1664
16. Lowrie E.G., and Lew N.L. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15 (1990) 458-482
17. Foley R.N., Parfrey P.S., Harnett J.D., et al. Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol 16 (1996) 386-393
18. Ganesh S.K., Stack A.G., Levin N.W., Hulbert-Shearon T., and Port F.K. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12 (2001) 2131-2138
19. Plantinga L.C., Fink N.E., Jaar B.G., et al. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: A prospective cohort study. BMC Health Serv Res 7 (2007) 5
20. Jadoul M., Albert J.M., Akiba T., et al. Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 70 (2006) 1358-1366
21. Danese M.D., Kim J., Doan Q.V., Dylan M., Griffiths R., and Chertow G.M. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47 (2006) 149-156
22. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42 suppl 3 (2003) S1-S202
23. Jindal K., Chan C.T., Deziel C., et al. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 17 suppl 1 (2006) S1-S27
24. Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, and the Royal College of General Practitioners. Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral (2006), Royal College of Physicians, London, UK
25. Elder G., Faull R., Branley P., and Hawley C. Management of bone disease, calcium, phosphate and parathyroid hormone. Nephrology 11 suppl 1 (2006) S230-S261
26. Cannata-Andía J.B., and Medical Working Group. Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant 15 suppl 5 (2000) S43
27. Vanbelleghem H., Vanholder R., Levin N.W., et al. The Kidney Disease: Improving Global Outcomes website: Comparison of guidelines as a tool for harmonization. Kidney Int 71 (2007) 1054-1061
28. Young E.W., Goodkin D.A., Mapes D.L., et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int Suppl 74 (2000) S74-S81
29. Pisoni R.L., Gillespie B.W., Dickinson D.M., et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology. Am J Kidney Dis 44 (2004) 7-15
30. Portale A.A. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. In: Favus M.J. (Ed). Blood calcium, phosphorus, and magnesium (1999), Lippincott, Williams & Wilkins, Philadelphia, PA 115-118
31. Klein J., and Moeschberger M. Survival Analysis Techniques for Censored and Truncated Data (1997), Springer, New York, NY 416-418
32. Port F.K., Wolfe R.A., Held P.J., and Young E.W. Random sample (DOPPS) versus census-based registry approaches to kidney disease research. Blood Purif 21 (2003) 85-88
33. Wald R., Tentori F., Tighiouart H., Zager P.G., and Miskulin D.C. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network. Am J Kidney Dis 49 (2007) 257-266
34. Faull R.J. Managing bone parameters in dialysis patients: International guideline conflicts. Semin Dial 20 (2007) 191-194
35. Clase C.M., Norman G.L., Beecroft M.L., and Churchill D.N. Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol Dial Transplant 15 (2000) 1841-1846
36. Johnston S.C. Combining ecological and individual variables to reduce confounding by indication: Case study-Subarachnoid hemorrhage treatment. J Clin Epidemiol 53 (2000) 1236-1241
37. Sigrist M.K., Devlin L., Taal M.W., Fluck R.J., and McIntyre C.W. Length of interdialytic interval influences serum calcium and phosphorus concentrations. Nephrol Dial Transplant 20 (2005) 1643-1646